Skip to menu Skip to content Skip to footer

1995

Conference Publication

Hpv16 E7 Transgenic Skin Is Not Rejected in E7 Immunized Mice

Frazer, I. H., Dunn, L. A., Fernando, G. J., Tindle, R. W., Leippe, D. M. and Lambert, P. F. (1995). Hpv16 E7 Transgenic Skin Is Not Rejected in E7 Immunized Mice. Keystone Symposia on Molecular & Cellular Biology, Keystone, CO United States, 16-23 January 1995 . NEW YORK: Wiley-Blackwell.

Hpv16 E7 Transgenic Skin Is Not Rejected in E7 Immunized Mice

1994

Conference Publication

A Transgenic Mouse Model of the Immunobiology of Hpv16 Induced Cervical-Cancer

Frazer, I. H., Lieppe, D., Lambert, P., Griep, A., Dunn, L., Tindle, R. W. and Fernando, G. (1994). A Transgenic Mouse Model of the Immunobiology of Hpv16 Induced Cervical-Cancer. Keystone Symposia on Molecular & Cellular Biology, Taos, New Mexico , 13 - 20 February 1994. NEW YORK: Wiley-Blackwell.

A Transgenic Mouse Model of the Immunobiology of Hpv16 Induced Cervical-Cancer

1994

Conference Publication

Small Synthetic Peptides as Vaccines - a Model Peptide Iscom Construct From Cancer-Associated Human Papillomavirus

Fernando, G. J. P., Tindle, R. W., Frazer, I. H., Stenzel, D. J., Merza, M. S. and Morein, B. (1994). Small Synthetic Peptides as Vaccines - a Model Peptide Iscom Construct From Cancer-Associated Human Papillomavirus. 11th Annual Meeting on Modern Approaches to New Vaccines, Cold Spring Harbor, NY United States, September 1993. PLAINVIEW: COLD SPRING HARBOR LABORATORY PRESS.

Small Synthetic Peptides as Vaccines - a Model Peptide Iscom Construct From Cancer-Associated Human Papillomavirus

1994

Conference Publication

Use of a Double Aro Salmonella Mutant to Stably Express Hbv16 E7 Protein Epitopes Carried by the Hbv Core Antigen

Londono, P., Chatfield, S., Tindle, R., Frazer, I. and Dougan, G. (1994). Use of a Double Aro Salmonella Mutant to Stably Express Hbv16 E7 Protein Epitopes Carried by the Hbv Core Antigen. In: Journal of Cellular Biochemistry. Keystone Symposia on Molecular & Cellular Biology, Taos, New Mexico , (232-232). 13 - 20 February 1994.

Use of a Double Aro Salmonella Mutant to Stably Express Hbv16 E7 Protein Epitopes Carried by the Hbv Core Antigen

1993

Conference Publication

Adjuvants Can Bias to Th1 or Th2 the Immune-Response to Hpv E7 Protein in Mice

Fernando, G. J., Zhou, J., Tindle, R. W. and Frazer, I. H. (1993). Adjuvants Can Bias to Th1 or Th2 the Immune-Response to Hpv E7 Protein in Mice. -, -, 1993. BETHESDA: Wiley-Blackwell.

Adjuvants Can Bias to Th1 or Th2 the Immune-Response to Hpv E7 Protein in Mice

1993

Conference Publication

An Improved Immunoassay for the E7 Protein of Hpv16

Dunn, L. A., Tindle, R. W., Fernando, G. J. and Frazer, I. H. (1993). An Improved Immunoassay for the E7 Protein of Hpv16. -, -, 1993. BETHESDA: Wiley-Blackwell.

An Improved Immunoassay for the E7 Protein of Hpv16

1993

Conference Publication

Use of Recombinant Hepatitis-B Core Antigen Particles to Deliver Hpv16-E7 Immunogenic Signals

Tindle, R., Londono, P., Herd, K., Frazer, I. and Dougan, G. (1993). Use of Recombinant Hepatitis-B Core Antigen Particles to Deliver Hpv16-E7 Immunogenic Signals. -, -, -. Oxford, United Kingdom: John Wiley & Sons.

Use of Recombinant Hepatitis-B Core Antigen Particles to Deliver Hpv16-E7 Immunogenic Signals

1993

Conference Publication

A Transgenic Mouse Model of the Immunobiology of Hpv16 Induced Cervical-Cancer

Frazer, I. H., Lieppe, D., Lambert, P., Griep, A., Tindle, R. W. and Fernando, G. (1993). A Transgenic Mouse Model of the Immunobiology of Hpv16 Induced Cervical-Cancer. -, -, 1993. BETHESDA: FEDERATION AMER SOC EXP BIOL.

A Transgenic Mouse Model of the Immunobiology of Hpv16 Induced Cervical-Cancer

1984

Conference Publication

A novel anti-myeloid monoclonal-antibody BI-3C5 recognizes early myeloid and some lymphoid precursors, and sub-classifies human acute leukemias

TINDLE, RW, NICHOLS, RAB, CATOVSKY, D and JANOSSY, G (1984). A novel anti-myeloid monoclonal-antibody BI-3C5 recognizes early myeloid and some lymphoid precursors, and sub-classifies human acute leukemias. , , . Larchmont: Mary Ann Liebert.

A novel anti-myeloid monoclonal-antibody BI-3C5 recognizes early myeloid and some lymphoid precursors, and sub-classifies human acute leukemias